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Differential expression of the CD4 and CD8 antigens on T lymphocytes has been used as a basis to construct models of thymic differentiation, and to identify functionally distinct subsets of T cells (1, 2) . In the thymus, most cells coexpress both CD4 and CD8, while minor subpopulations express the phenotypes CD4-,8-; CD4+,8-; and CD4-,8 + (1, 2). It has been proposed that during thymic ontogeny CD4-,8-precursor cells differentiate into CD4÷,8 + thymocytes. Upon maturation, CD4+,8 + thymocytes acquire the CD3/Ti complex and presumably lose either CD4 or CD8, then CD3÷,4+,8 -and CD3+,4-,8 + T lymphocytes migrate into peripheral tissues (1, 2) . Mature CD3+,4+,8 -T cells augment Ig secretion by B lymphocytes and facilitate the generation of cytotoxic T cells, whereas CD3+,4-,8 + T cells predominately mediate cytotoxicity and immune suppression (3, 4) . In general, antigenic recognition by CD4 + T cells is restricted by class II MHC gene products, whereas antigenic recognition by CD8 ÷ cells is restricted by class I MHC antigens (5, 6) . It has been generally accepted that all peripheral T cells express either CD4 or CD8, with a minor population expressing both antigens. However, we have recently observed that a small subset of human peripheral blood CD3 + T lymphocytes express neither CD4 nor CD8. Herein, we describe the characteristics of this unique subset of T cells.
Materials and Methods
Isolation of Peripheral Blood CD3+,4-,8 -T Lymphocytes.
Mononuclear cells from normal peripheral blood (Stanford Blood Center, Palo Alto, CA) were isolated using Ficoll/Hypaque. Monocytes were depleted by plastic adherence. Nonadherent cells were stained with a mixture of FITC-conjugated anti-Leu-2 (CD8), FITC-conjugated anti-Leu-3 (CD4), and phycoerythrin (PE)-conjugated anti-Leu-4 (CD3) (7) . After extensive washing in ice cold PBS, the cells were resuspended in PBS containing 1% FCS. Lymphocytes expressing CD3, but lacking both CD4 and CD8, would therefore show specific red (PE) fluorescence, but not green (FITC) fluorescence, CD3+,4-,8 -cells were isolated to >95% purity using a FACS 440 (Becton Dickinson lmmunocytometry Systems, Mountain View, CA) (7). Fluorochrome-conjugated, isotype-matched control antibodies were used to establish the specificity of antibody binding (7) .
Antibodies. Anti-Leu-1, -Leu-2, -Leu-3, -Leu-4, -Leu-5, -Leu-6, -Leu-11, and -Leu-12 react with the CD5, CD8, CD4, CD3, CD2, CD1, CD16, and CD19 differentiation antigens, respectively. Anti-Leu-19 reacts with the Leu-19 (NKH-1) antigen, which is present on NK cells and a subset of T lymphocytes (8) .
lmmunofluorescence and Flow Cytometry. Methods of immunofluorescence, flow cytometry, and data analysis have been presented elsewhere (7, 9) .
Cytotoxicity Assays. 5~Cr-labeled tumor cells were used as targets in a 4-h radioisotope release assay (7) .
Cell Culture. anti-Leu-4 gave an identical profile, indicating that these cells were CD3+,CD8 a~=+ (not shown). No CD4 + lymphocytes were detected in these cultures, a, anti.
Biologicals, Lexena, KS), 1 mM glutamine, 100 #g/ml gentamicin, and 1000 U/ml rlL-2 (Cetus Corp., Emeryville, CA).
Results and Discussion Peripheral blood lymphocytes from normal donors were stained with PE antiLeu-4 (CD3) and a mxiture of FITC anti-Leu-2 (CD8) and FITC anti-Leu-3 (CD4) and were analyzed by flow cytometry. A small subset of cells expressed CD3 antigen (a component of the T cell antigen receptor), but lacked both CD4 and CD8 (Fig. 1) . Based on analysis of >20 normal blood donors, ~3% of blood lymphocytes comprised CD3+,4-,8 -T lymphocytes (range, <0.5-23%) (~78% of lymphocytes were CD3+). The specificity of the staining was confirmed by showing that an identical percentage of lymphocytes was observed using a reciprocal set of reagents (i.e., FITC anti-Leu-4 and a mixture of PE anti-Leu-2 and PE anti-Leu-3), and by direct three-color immunofluorescence analysis using FITC anti-Leu-2, PE anti-Leu-3, and APC anti-Leu-4 (not shown). 1 By threecolor immunofluorescence, 2 we also determined that >90% of the CD3+,4-,8 -Identical results have also been obtained using the T3, T4 and T8 mAbs (Coulter Immunology, Hialeah, FL).
This was determined by three-color immunofluorescence by staining lymphocytes with APC streptavidin/biotin anti-Leu-4 (CD3), a mixture of PE anti-Leu-2 and PE anti-Leu-3, and a third CD3÷,4-,8 -iymphocytes were isolated to >90% purity using a FACS. 105 cells were placed into culture in medium containing rIL-2. After 2 wk, -5 × 106 cells were recovered and reanalyzed for expression of CD4 and CD8. >99% of the rIL-2-cultured lymphocytes expressed CD3, and 90% were CD3+,4-,8 - (Fig.  1B) . We failed to detect any cells (<0.5%) that expressed either CD4 or CD16. These results clearly show that CD3+,4-,8 -T lymphocytes can proliferate in response to rIL-2 without deliberate antigenic stimulation and that the CD3+,4-,8 -phenotype is stably maintained. It should be noted however that 10% of the rIL-2-cuitured CD3 + T cells did express CD8 antigen, but in approximately one-tenth of the amount present on typical blood CD3+,8 + T lymphocytes. Lymphocytes expressing "dim" CD8 have been described; however, in these prior reports most CD8 dim+ cells lacked CD3 and were CD3-, CD16 + NK cells (7) . Whether CD3+,CD4-,CD8 dim+ lymphocytes were generated from the CD3÷,4-,8 -population or were a contaminant in the isolation procedure is unknown.
Morphological examination revealed that >80% of CD3+,4-,8 -cells cultured only in rIL-2 were large lymphoblasts with abundant cytoplasm containing predominant azurophilic granules (Fig. 2 A) . In contrast, >90 % of freshly isolated CD3+,4-,8 -cells were agranular lymphocytes, although a small proportion of granular cells was observed in some donors (Fig. 2B) . Since both NK cells and some CTL possess this characteristic granular morphology, these cells were tested for cytotoxic activity. CD3+,4-,8 -T cells cultured only in rIL-2 lysed NKsensitive K562 and NK-insensitive JY targets (Fig. 3A) . Since K562 lacks cell surface expression of both class I and II MHC antigens, these results show that rIL-2-cultured CD3+,4-,8 -T lymphocytes recognize and lyse tumor cell targets without MHC restriction. Freshly isolated CD3+,4-,8 -T cells did not lyse K562 (Fig. 3B) . The rIL-2-activated CD3+,4-,8 -cells could be distinguished from freshly isolated CD3+,4-,8 -cells based on expression of Leu-19 antigen. >70% of rIL-2-stimulated CD3+,4-,8 -cells expressed Leu-19, whereas generally <10% of freshly isolated CD3+,4-,8 -cells expressed Leu-19. Recently, we have shown that the Leu-19 antigen is expressed on essentially all peripheral blood CD3-NK cells, but is also present on a small subset of freshly isolated peripheral blood CD3 + T lymphocytes (most of which express CD8) that mediate non-MHCrestricted cytotoxicity (8) .
The cytotoxicity mediated by rIL-2-cultured CD3+,4-,8 -lymphocytes against K562 was significantly augmented by the presence of soluble anti-Leu-4 antibody in the cytotoxicity assay (Fig. 4) . Although anti-CD3 antibodies generally inhibit the cytotoxic function of antigen-specific CTL activity against the specific target antigen, it has been observed that anti-CD3 antibodies actually induce nonspecific iyse of inappropriate targets (10) . The finding that anti-CD3 induces, rather than inhibits, the cytotoxicity of the rIL-2-activated CD3+,4-, 8 -cells suggests that this population may be polyclonal, containing cytotoxic cells of several specificities which are triggered in the presence of anti-CD3.
These results are compatible with the hypothesis that the peripheral blood CD3+,4-,8 -population is polyclonal, and that a Leu-19 + cytotoxic subset within the C D 3 + , 4 -, 8 -p o p u l a t i o n can p r o l i f e r a t e d i r e c t l y in r e s p o n s e to r l L -2 , w i t h o u t d e l i b e r a t e a n t i g e n i c stimulation. F u r t h e r studies on the p r e c u r s o r s o f the cytotoxic cells within the C D 3 + , 4 -, 8 -subset will b e necessary to identify the f r e q u e n c y a n d p h e n o t y p e o f these cells, a n d investigate t h e i r r e l a t i o n s h i p to the l y m p h o k i n ea c t i v a t e d killer p h e n o m e n o n . Fig. 1 Summary CD3 + T lymphocytes expressing neither CD4 nor CD8 antigens exist in normal human peripheral blood in low frequency (~3% of lymphocytes). The CD3+,4-,8 -phenotype was stably maintained after in vitro culture in IL-2. Culture of CD3+,4-,8 -cells in only rlL-2 generated cytotoxic T cells that lysed NK-sensitive and NK-insensitive tumor cell targets without MHC restriction. These experiments clearly show that phenotypically and functionally competent T cells expressing neither CD4 nor CD8 are present in normal peripheral blood.
